2006
DOI: 10.3171/jns.2006.104.6.969
|View full text |Cite
|
Sign up to set email alerts
|

Traumatic carotid artery–cavernous sinus fistula treated with a covered stent

Abstract: The authors describe the cases of two patients with unilateral traumatic caroticocavernous fistulas in whom a self-expanding covered stent was successfully used to obliterate the fistula after failed occlusion with detachable balloons and coils. They discuss this option as a primary therapeutic modality in cases in which detachable balloons or coils, with or without a bare stent, have failed to obliterate the fistula. The placement of a covered stent to occlude the lesion from the outset may represent a new th… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4

Citation Types

1
18
1
5

Year Published

2007
2007
2016
2016

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 35 publications
(25 citation statements)
references
References 27 publications
1
18
1
5
Order By: Relevance
“…It also supports the prior experience by Madam et al, 20 who administered clopidogrel for 3 months and ASA for 6 months in 2 patients with CCF and stent grafts, who did not develop signs of thrombosis and demonstrated patency of the artery at 6 months angiographic follow-up. From prior animal studies, we know that PTFE-covered stents are well endothelized (over 90% of their surface area) in 4 weeks.…”
Section: Discussionsupporting
confidence: 76%
See 4 more Smart Citations
“…It also supports the prior experience by Madam et al, 20 who administered clopidogrel for 3 months and ASA for 6 months in 2 patients with CCF and stent grafts, who did not develop signs of thrombosis and demonstrated patency of the artery at 6 months angiographic follow-up. From prior animal studies, we know that PTFE-covered stents are well endothelized (over 90% of their surface area) in 4 weeks.…”
Section: Discussionsupporting
confidence: 76%
“…36 Our observations add to prior reports in which minimal or no intimal hyperplasia was identified in patients treated with stent grafts for a vascular process other than atherosclerotic vaso-occlusive disease. [20][21][22]24,25,30,32,37,38 This contrasts with the experience reported in the coronary and venous bypass circulation, where significant restenosis was reported in approximately 30% of the patients with known atherosclerotic disease and associated risk factors. 39,40 Despite the encouraging preliminary results in our series and other similar series previously cited, the number of patients with CCF treated with covered stents remains small, and additional investigation is required to determine the long-term outcome of this treatment method.…”
Section: Discussioncontrasting
confidence: 52%
See 3 more Smart Citations